Wide Frequency Band Test of Hearing in Veterans (CWTBAFV)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02019888|
Recruitment Status : Enrolling by invitation
First Posted : December 24, 2013
Last Update Posted : March 30, 2018
|Condition or disease|
|Hearing Loss, Sensorineural Hearing Loss, Conductive Hearing Loss, Mixed Conductive-Sensorineural Otosclerosis Tympanic Membrane Perforation Otitis Media With Effusion Cholesteatoma|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||640 participants|
|Official Title:||Comprehensive Wide Bandwidth Test Battery of Auditory Function in Veterans|
|Actual Study Start Date :||December 1, 2014|
|Estimated Primary Completion Date :||November 1, 2018|
|Estimated Study Completion Date :||January 31, 2019|
Normal hearing adults
Adults between 20 and 79 years old with hearing at all audiometric frequencies between 250 and 8000 Hz at less than or equal to 25 dB HL
Adults with sensory neural hearing loss
Adults between 20 and 79 years old with sensory neural hearing at one or more audiometric frequencies between 250 and 8000 Hz.
Adults with middle ear disorders
Adults between 20 and 89 years old with middle ear disorders: tympanic membrane perforation, serous otitis media, cholesteatoma, otosclerosis, and unspecified middle ear disorders.
- Middle ear test [ Time Frame: Assessed at time of enrollment ]The standard clinical middle ear test, 226 Hz tympanometry, and the experimental wideband middle ear tests of absorbance and admittance.
- Middle ear muscle reflex test [ Time Frame: Assessed at time of enrollment ]The standard clinical middle ear muscle reflex test assessed with 226 Hz admittance changes, and the experimental wideband middle ear muscle reflex test assessed with wideband admittance and absorbance changes.
- Wideband otoacoustic emission test [ Time Frame: Assessed at time of enrollment ]An otoacoustic emission test assessed using a transient wideband stimulus from 1000 to 8000 Hz.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02019888
|United States, Oregon|
|VA Portland Health Care System, Portland, OR|
|Portland, Oregon, United States, 97239|
|United States, Tennessee|
|Mountain Home VA Medical Center James H. Quillen VA Medical Center, Mountain Home, TN|
|Mountain Home, Tennessee, United States, 37684|
|Principal Investigator:||M. Patrick Feeney, PhD||VA Portland Health Care System, Portland, OR|